Simvastatin for mTBI

Simvastatin: Proof-of-Concept for Prevention of Neurodegeneration in Mild TBI

NCT01952288•VA Office of Research and Development

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

TBI-Traumatic Brain Injury

Interventions

simvastatin

Placebo Oral Tablet

Locations

United States

Locations (1)

VA Puget Sound Health Care System Seattle Division, Seattle, WA

Seattle, Washington, United States

Key Dates

Start Date

September 16, 2013

Primary Completion Date

June 20, 2017

Completion Date

June 20, 2017

Last Updated

December 15, 2021

Sponsors

Lead Sponsor

VA Office of Research and Development

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 15, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions